Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: a study of formulation optimization, toxicity, and pharmacokinetics
about
Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: a study of formulation optimization, toxicity, and pharmacokinetics
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhancement of the bioavailabi ...... toxicity, and pharmacokinetics
@en
Enhancement of the bioavailabi ...... oxicity, and pharmacokinetics.
@nl
type
label
Enhancement of the bioavailabi ...... toxicity, and pharmacokinetics
@en
Enhancement of the bioavailabi ...... oxicity, and pharmacokinetics.
@nl
prefLabel
Enhancement of the bioavailabi ...... toxicity, and pharmacokinetics
@en
Enhancement of the bioavailabi ...... oxicity, and pharmacokinetics.
@nl
P2093
P2860
P356
P1433
P1476
Enhancement of the bioavailabi ...... toxicity, and pharmacokinetics
@en
P2093
Alex Chang
Kathy Qian Luo
Xiaofeng Liu
P2860
P304
12013-12030
P356
10.18632/ONCOTARGET.14481
P407
P577
2017-01-04T00:00:00Z